A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration.
Jaffe, Glenn, Dean Eliott, John Wells, Jonathan Prenner, Andras Papp, and Samir Patel. 2016. “A Phase 1 Study of Intravitreous E10030 in Combination With Ranibizumab in Neovascular Age-Related Macular Degeneration.”. Ophthalmology 123 (1): 78-85.